Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, and Head of Development
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
Elevidys is currently the only approved gene therapy that targets the root cause of Duchenne
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
Ibrutinib tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad
Revenue increased 11.4 per cent to Rs. 8,545 crore
Upgrades 2025 full-year CDMO sales and margin outlook
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
Subscribe To Our Newsletter & Stay Updated